Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/24
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 10/30/24
End: 01/31/27
Due: 01/31/28
Phase: N/A
Priority: Normal
Start: 04/15/19
End: 10/08/24
Due: 10/08/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers | NCT06523803 | Zymeworks BC Inc. | user2@example.com | None | 2024-09-30 | 2027-12-31 | 2028-12-31 | - | - | 2025-07-14 |
| A Study of ZW191 in Participants With Solid Tumors | NCT06555744 | Zymeworks BC Inc. | user2@example.com | None | 2024-10-30 | 2027-01-31 | 2028-01-31 | - | - | 2025-07-14 |
| A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers | NCT03821233 | Zymeworks BC Inc. | user2@example.com | None | 2019-04-15 | 2024-10-08 | 2025-10-08 | - | - | 2025-07-14 |